有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | N-[(3S)-1,1-dioxothiolan-3-yl]-N-(2-methoxyethyl)-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C11H18N4O4S2 |
|
—— | N-benzyl-N-(furan-2-ylmethyl)-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C16H16N4O2S |
|
—— | N-[(3R)-1,1-dioxothiolan-3-yl]-N-(2-methoxyethyl)-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C11H18N4O4S2 |
|
—— | N-[3-(N-methylanilino)propyl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C14H19N5OS |
|
—— | N-methyl-N-[(4-methylsulfanylphenyl)methyl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C13H16N4OS2 |
|
—— | N-propyl-N-[(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)methyl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C14H16N6O2S2 |
|
—— | N-[(R)-phenyl(thiophen-2-yl)methyl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C15H14N4OS2 |
|
—— | N-ethyl-N-[(3-fluorophenyl)methyl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C13H15FN4OS |
|
—— | 2-(5-Bromothiophen-2-yl)-5-[(1-oxidopyridin-1-ium-2-yl)sulfanylmethyl]-1,3,4-oxadiazole | —— | C12H8BrN3O2S2 |
|
—— | N-[(S)-(4-fluorophenyl)-thiophen-2-ylmethyl]-2-(1-oxidopyridin-1-ium-2-yl)sulfanylacetamide | —— | C18H15FN2O2S2 |
|
—— | N-[[4-(dimethylamino)phenyl]methyl]-2-(1-oxidopyridin-1-ium-2-yl)sulfanyl-N-[[(2R)-oxolan-2-yl]methyl]acetamide | —— | C21H27N3O3S |
|
—— | 1-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-(1-oxidopyridin-1-ium-2-yl)sulfanylethanone | —— | C16H15NO4S |
|
—— | N-[[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-N-cyclopropyl-2-(1-oxidopyridin-1-ium-2-yl)sulfanylacetamide | —— | C19H17ClN4O3S |
|
—— | 3-[(1-Oxidopyridin-1-ium-2-yl)sulfanylmethyl]-5-phenyl-1,2-oxazole | —— | C15H12N2O2S |
|
—— | 1-[(Z)-3-(furan-2-yl)prop-2-enyl]-4-[(4-methyl-5-methylsulfanyl-1,2,4-triazol-3-yl)methyl]piperidine | —— | C17H24N4OS |
|
—— | 1-(Furan-2-ylmethyl)-3-(2-phenylsulfanylethyl)thiourea | —— | C14H16N2OS2 |
|
—— | 4-[(5-methyl-1,2-oxazol-3-yl)methyl]-N-(2-phenylsulfanylethyl)piperazine-1-carbothioamide | —— | C18H24N4OS2 |
|
—— | 1-(2-Morpholin-4-ylethyl)-3-(2-phenylsulfanylethyl)thiourea | —— | C15H23N3OS2 |
|
—— | 1-(2-Adamantyl)-3-(2-phenylsulfanylethyl)thiourea | —— | C19H26N2S2 |
|
—— | 1-(dimethylamino)-1-[(3R)-1,1-dioxothiolan-3-yl]-3-(2-phenylsulfanylethyl)thiourea | —— | C15H23N3O2S3 |
|
—— | 1-(2-phenylsulfanylethyl)-3-[(R)-phenyl(thiophen-2-yl)methyl]thiourea | —— | C20H20N2S3 |
|
—— | N-[2-(4-chlorophenyl)sulfanylethyl]-4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazin-4-ium-1-carbothioamide | —— | C18H24ClN4OS2+ |
|
—— | 1-Benzyl-3-(2-phenylsulfanylethyl)thiourea | —— | C16H18N2S2 |
|
—— | 1-Ethyl-3-[3-[4-(2-methylpropyl)-5-methylsulfanyl-1,2,4-triazol-3-yl]propyl]thiourea | —— | C13H25N5S2 |
|
—— | 1-Cyclopropyl-3-[3-[4-(2-methylpropyl)-5-methylsulfanyl-1,2,4-triazol-3-yl]propyl]thiourea | —— | C14H25N5S2 |
|
—— | 4-[(5-methyl-1,2-oxazol-3-yl)methyl]-N-(2-phenylsulfanylethyl)piperazin-4-ium-1-carbothioamide | —— | C18H25N4OS2+ |
|
—— | 4-(4-Bromophenyl)sulfanyl-3-nitrobenzenesulfonamide | —— | C12H9BrN2O4S2 |
|
—— | 1-[2-(2-Fluorophenyl)ethyl]-3-(2-phenylsulfanylethyl)thiourea | —— | C17H19FN2S2 |
|
—— | 2-(4-Bromophenyl)sulfanyl-5-piperidin-1-ylsulfonylpyridine | —— | C16H17BrN2O2S2 |
|
—— | N-methyl-4-(1-methylimidazol-2-yl)sulfanyl-3-nitrobenzenesulfonamide | —— | C11H12N4O4S2 |
|
—— | N-tert-butyl-4-(1-methylimidazol-2-yl)sulfanyl-3-nitrobenzenesulfonamide | —— | C14H18N4O4S2 |
|
—— | N-(4-methylcyclohexyl)-4-(1-methylimidazol-2-yl)sulfanyl-3-nitrobenzenesulfonamide | —— | C17H22N4O4S2 |
|
—— | (3S,5S)-3,5-dimethyl-1-[4-(1-methylimidazol-2-yl)sulfanyl-3-nitrophenyl]sulfonylpiperidine | —— | C17H22N4O4S2 |
|
—— | 4-[[(7R)-7-methyl-4-(1-methyltetrazol-5-yl)sulfanyl-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl]methyl]morpholin-4-ium | —— | C18H24N7OS2+ |
|
—— | 10-[(4-Methylpiperidin-1-yl)methyl]-12-(1-methyltetrazol-5-yl)sulfanyl-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraene | —— | C18H23N7S2 |
|
—— | 12-(1-Methyltetrazol-5-yl)sulfanyl-10-(phenylsulfanylmethyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraene | —— | C18H16N6S3 |
|
—— | N-ethyl-6-(1-methyltetrazol-5-yl)sulfanyl-N-phenylpyridine-3-sulfonamide | —— | C15H16N6O2S2 |
|
—— | 4-[[12-(1-Methylimidazol-2-yl)sulfanyl-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-10-yl]methyl]morpholin-4-ium | —— | C18H22N5OS2+ |
|
—— | 12-(1-Methylimidazol-2-yl)sulfanyl-10-[(4-methylpiperidin-1-yl)methyl]-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraene | —— | C20H25N5S2 |
|
—— | 4-[[(7S)-7-methyl-4-(1-methyltetrazol-5-yl)sulfanyl-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl]methyl]morpholine | —— | C18H23N7OS2 |
|
—— | 4-[[5,6-Dimethyl-4-(1-methyltetrazol-5-yl)sulfanylthieno[2,3-d]pyrimidin-2-yl]methyl]morpholine | —— | C15H19N7OS2 |
|
—— | 4-(1-methylimidazol-2-yl)sulfanyl-3-nitro-N-propan-2-ylbenzenesulfonamide | —— | C13H16N4O4S2 |
|
—— | 4-(2-chlorophenyl)sulfanyl-N-methyl-3-nitrobenzenesulfonamide | —— | C13H11ClN2O4S2 |
|
—— | 4-chloro-5-(4-chloro-benzylsulfanyl)-2-phenyl-2<i>H</i>-pyridazin-3-one | 16461-50-0 | C17H12Cl2N2OS |
|
—— | (2R)-2-[(4-amino-5-methyl-1,2,4-triazol-3-yl)sulfanyl]-N-[(1R,2R)-2-methylcyclohexyl]propanamide | —— | C13H23N5OS |
|
—— | N,N-diethyl-3-nitro-4-phenylsulfanylbenzenesulfonamide | —— | C16H18N2O4S2 |
|
—— | N-[2-(dimethylamino)ethyl]-3-nitro-4-phenylsulfanylbenzenesulfonamide | —— | C16H19N3O4S2 |
|
—— | 2-Phenylsulfanyl-5-piperidin-1-ylsulfonylpyridine | —— | C16H18N2O2S2 |
|
—— | 12-Phenylsulfanyl-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraene | —— | C15H12N2S2 |
|
—— | 1-Methyl-4-(3-nitro-4-phenylsulfanylphenyl)sulfonylpiperazine | —— | C17H19N3O4S2 |
|